- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03348332
Effect During Pregnancy and Intrapartum Health
November 16, 2017 updated by: María Perales Santaella, Technical University of Madrid
Effect of Supervised Exercise During Pregnancy on Maternal and Newborn Intrapartum Health
Assessing the role of moderate exercise in newborn intrapartum variables have showed to be crucial not only on prescribing exercise safely, but also on understanding its impact on the prevention of some cardio-metabolic diseases after labor.
Clarify this concept will be essential on reducing human risk for some chronic diseases through implementing supervised exercise programs during such a critical period.
Study Overview
Detailed Description
The aim of this randomized controlled trial was to evaluate the effect of combined exercise (aerobic and strength exercise) on maternal and newborn intrapartum variables.
Study Type
Interventional
Enrollment (Actual)
530
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Madrid, Spain, 28040
- Universidad Politecnica de Madrid
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Being healthy and able to exercise following American College of Obstetricians and Gynecologists (ACOG) guidelines.
- Being able to communicate in spanish
- Giving birth at Hospital Universitario de Puerta de Hierro (Majadahonda); Hospital Universitario Severo Ochoa (Leganés).
Exclusion Criteria:
- Multiparity
- Obstetrician complications
- Being interested in the study after 18 weeks
- Not being regular in physical exercise program
- Younger than 18 years old
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Sedentary pregnant women
Pregnant women who do not exercise regularly during pregnancy
|
|
Experimental: Exercise pregnant women
Pregnant women who participate in a supervised exercise program
|
A supervised physical conditioning program of three 55-60 minute sessions per week during whole pregnancy (from week 10 to 39) was conducted.
Each session consisted of 25-30 minutes of cardiovascular exercise,10 minutes of specific exercises (strength and balance exercises), and 10 minutes of pelvic floor muscles training.
Aerobic activity was prescribed at light to moderate intensity, aiming for 55-60 of maximal heart rate.
All subjects wore a heart rate (HR) monitor during the training sessions to control the intensity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stage of labor
Time Frame: At the moment of delivery
|
Duration stages of labor (min)
|
At the moment of delivery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maternal gestational weight gain
Time Frame: 40-42 weeks of gestation
|
Change from baseline in maternal gestational weight gain (g)
|
40-42 weeks of gestation
|
Glucose state
Time Frame: 24-26 weeks of gestation
|
Maternal glucose state (O´Sullivan test)
|
24-26 weeks of gestation
|
Blood pressure
Time Frame: 12, 20 and 34 weeks of gestation
|
Maternal blood pressure during pregnancy (mmHg)
|
12, 20 and 34 weeks of gestation
|
Gestational age
Time Frame: At the moment of delivery
|
Gestational age (weeks)
|
At the moment of delivery
|
Birth weight
Time Frame: At the moment of delivery
|
Newborn weight (g)
|
At the moment of delivery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Rubén Barakat Carballo, PhD, Universidad Politécnica de Madrid.
- Principal Investigator: María Perales Santaella, PhD, Universidad Politécnica de Madrid.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2012
Primary Completion (Actual)
June 1, 2015
Study Completion (Actual)
September 1, 2016
Study Registration Dates
First Submitted
November 16, 2017
First Submitted That Met QC Criteria
November 16, 2017
First Posted (Actual)
November 20, 2017
Study Record Updates
Last Update Posted (Actual)
November 20, 2017
Last Update Submitted That Met QC Criteria
November 16, 2017
Last Verified
November 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- Intrapartum assessment
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
University Hospital, ToursCompleted
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Hopital Antoine BeclereUnknown
-
Turku University HospitalUniversity of TurkuCompleted
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium
Clinical Trials on Exercise pregnant women
-
Kanuni Sultan Suleyman Training and Research HospitalAyşegül Bestel; İbrahim Polat; Merve Aldıkaçtıoğlu TalmaçCompletedDepression, Postpartum | Anxiety | COVIDTurkey
-
University Hospital, Strasbourg, FranceRecruitingPregnancy | Preterm Birth | Low Birth Weight | Air PollutionFrance
-
Materno-Perinatal Hospital of the State of MexicoUniversidad Autonoma del Estado de Mexico; Ciprés Grupo Médico CGM SCCompletedCorrelation of Cytokines and Anthropometry in PregnancyMexico
-
University Hospital, BordeauxSociété Francophone du DiabèteRecruitingGestational Diabetes Mellitus in Pregnancy | Macrosomia, FetalFrance
-
Norwegian School of Sport SciencesCompletedPregnancy | Excessive Weight GainNorway
-
West China HospitalXiamen Health and Medical Big Data Center, Xiamen Health CommissionActive, not recruitingPregnant Women | Registries
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedAcquired Immunodeficiency Syndrome | HIV Seropositivity | Pregnancy, High Risk
-
Tel-Aviv Sourasky Medical CenterUnknownPregnancy, Prolonged
-
University of Maryland, BaltimoreBill and Melinda Gates FoundationActive, not recruitingStillbirths and Infant MortalityMali
-
University Hospital, Clermont-FerrandCompletedPregnancy Related | Sedentary Behavior | Sedentary Time | Perinatal Problems | Morbidity;PerinatalFrance